@article{TGH3626,
author = {Zhong-He Ji and Kai-Wen Peng and Yan Li},
title = {Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer},
journal = {Translational Gastroenterology and Hepatology},
volume = {1},
number = {7},
year = {2016},
keywords = {},
abstract = {Peritoneal carcinomatosis (PC) is one of the most common causes of death in gastric cancer patients. Intraperitoneal free cancer cells (IFCCs) play a very important role in forming PC, but the administration of intraperitoneal chemotherapy (IPC) and/or hyperthermic intraperitoneal chemotherapy (HIPEC) could be an effective treatment for IFCCs. This review focuses on the origin of IFCCs, the mechanism of PC formatting, the rationale of IPC/HIPEC, and the current clinical trials on IPC/HIPEC to treat advanced gastric cancer patients.},
issn = {2415-1289}, url = {https://tgh.amegroups.org/article/view/3626}
}